The endocrinopathies of anorexia nervosa

Endocrine Practice

Volumn 14, Issue 8, 2008, Pages 1055-1063

  Usdan, Lisa S ^a,b   Khaodhiar, Lalita ^a,b   Apovian, Caroline M ^a,b  

^a BOSTON MEDICAL CENTER   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GHRELIN; GROWTH HORMONE; LEPTIN;

ADRENAL GLAND; ADULT; ANOREXIA NERVOSA; APPETITE; BODY HEIGHT; BONE METABOLISM; CASE REPORT; CONVALESCENCE; DISEASE COURSE; ENDOCRINE DISEASE; FEMALE; GONAD; HORMONE RESISTANCE; HUMAN; HYPOPHYSIS; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INFERTILITY; MALNUTRITION; NEUROENDOCRINE SYSTEM; OSTEOPOROSIS; PARENTERAL NUTRITION; PATHOPHYSIOLOGY; PHYSICAL EXAMINATION; REFEEDING SYNDROME; REVIEW; SHORT STATURE; STARVATION; THYROID GLAND;

ANOREXIA NERVOSA; ENDOCRINE SYSTEM DISEASES; FEMALE; HUMANS; MALNUTRITION; REFEEDING SYNDROME; YOUNG ADULT;

EID: 65849133641     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP.14.8.1055     Document Type: Review

References (89)

1. Hoek HW, van Hoeken D. Review of the prevalence and incidence of eating disorders. Int J Eat Disord. 2003;34: 383-396.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed, Text Revision. Washington, DC: American Psychiatric Association, 2000.
3. Katz MG, Vollenhoven B. The reproductive endocrine consequences of anorexia nervosa. BJOG. 2000;107:707-713.
4. Couzinet B, Young J, Brailly S, Le Bouc Y, Chanson P, Schaison G. Functional hypothalamic amenorrhea: A partial and reversible gonadotropin deficiency of nutritional origin. Clin Endocrinol (Oxf). 1999;50:229-235.
5. Støving RK, Hangaard J, Hansen-Nord M, Hagen C. A review of endocrine changes in anorexia nervosa. J Psychiatr Res. 1999;33:139-152.
6. Braat DD, Schoemaker R, Schoemaker J. Life table analysis of fecundity in intravenously gonadotropin-releasing hormone-treated patients with normogonadotropic and hypogonadotropic amenorrhea. Fertil Steril. 1991;55:266-271.
7. Boyar RM, Katz J, Finkelstein JW, et al. Anorexia nervosa. Immaturity of the 24-hour luteinizing hormone secretory pattern. N Engl J Med. 1974;291:861-865.
8. Savastano S, Tommaselli AP, Valentino R, et al. Changes in the glycosylation pattern of circulating gonadotropins after acute administration of gonadotropin-releasing hormone in patients with anorexia nervosa. Eur J Endocrinol. 1998;138:76-81.
9. Tommaselli AP, Valentino R, Savastano S, et al. Altered glycosylation of pituitary gonadotropins in anorexia nervosa: An alternative explanation for amenorrhea. Eur J Endocrinol. 1995;132:450-455.
10. Schweiger U. Menstrual function and luteal-phase deficiency in relation to weight changes and dieting. Clin Obstet Gynecol. 1991;34:191-197.
11. Loucks AB, Heath EM. Dietary restriction reduces luteinizing hormone (LH) pulse frequency during waking hours and increases LH pulse amplitude during sleep in young menstruating women. J Clin Endocrinol Metab. 1994;78:910-915.
12. Reame NE, Sauder SE, Case GD, Kelch RP, Marshall JC. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: Evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation. J Clin Endocrinol Metab. 1985;61:851-858.
13. Muñoz MT, Argente J. Anorexia nervosa in female adolescents: Endocrine and bone mineral density disturbances. Eur J Endocrinol. 2002;147:275-286.
14. Bates GW, Bates SR, Whitworth NS. Reproductive failure in women who practice weight control. Fertil Steril. 1982;37:373-378.
15. Stewart DE, Robinson E, Goldbloom DS, Wright C. Infertility and eating disorders. Am J Obstet Gynecol. 1990;163:1196-1199.
16. Golden NH, Jacobson MS, Schebendach J, Solanto MV, Hertz SM, Shenker IR. Resumption of menses in anorexia nervosa. Arch Pediatr Adolesc Med. 1997;151:16-21.
17. van Elburg AA, Eijkemans MJ, Kas MJ, et al. Predictors of recovery of ovarian function during weight gain in anorexia nervosa. Fertil Steril. 2007;87:902-908.
18. Kohmura H, Miyake A, Aono T, Tanizawa O. Recovery of reproductive function in patients with anorexia nervosa: A 10-year follow-up study. Eur J Obstet Gynecol Reprod Biol. 1986;22:293-296.
19. Misra M, Prabhakaran R, Miller KK, et al. Role of cortisol in menstrual recovery in adolescent girls with anorexia nervosa. Pediatr Res. 2006;59:598-603.
20. Rickenlund A, Thorén M, Carlström K, von Schoultz B, Hirschberg AL. Diurnal profiles of testosterone and pituitary hormones suggest different mechanisms for menstrual disturbances in endurance athletes. J Clin Endocrinol Metab. 2004;89:702-707.
21. Kronenberg HM, Melmed S, Polonsky KS, Larsen PR, eds. Williams Textbook of Endocrinology. 11th ed. Philadelphia, PA: Saunders Elsevier, 2008.
22. Miyai K, Yamamoto T, Azukizawa M, Ishibashi K, Kumahara Y. Serum thyroid hormones and thyrotropin in anorexia nervosa. J Clin Endocrinol Metab. 1975; 40:334-338.
23. Croxson MS, Ibbertson HK. Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa. J Clin Endocrinol Metab. 1977;44:167-174.
24. Moshang T Jr, Parks JS, Baker L, et al. Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metab. 1975;40:470-473.
25. Spaulding SW, Chopra IJ, Sherwin RS, Lyall SS. Effect of caloric restriction and dietary composition of serum T3 and reverse T3 in man. J Clin Endocrinol Metab. 1976;42:197-200.
26. Leslie RD, Isaacs AJ, Gomez J, et al. Hypothalamo-pituitary- thyroid function in anorexia nervosa: Influence of weight gain. Br Med J. 1978;2:526-528.
27. Støving RK, Bennedbaek FN, Hegedüs L, Hagen C. Evidence of diffuse atrophy of the thyroid gland in patients with anorexia nervosa. Int J Eat Disord. 2001;29:230-235.
28. Brambilla F, Santonastaso P, Caregaro L, Favaro A. Disorders of eating behavior: Correlation between hypothalamo-pituitary-thyroid function and psychopathological aspects. Psychoneuroendocrinology. 2006;31:131-136.
29. Walsh BT, Katz JL, Levin J, et al. Adrenal activity in anorexia nervosa. Psychosom Med. 1978;40:499-506.
30. Misra M, Miller KK, Almazan C, et al. Alterations in cortisol secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2004;89:4972-4980.
31. Gold PW, Gwirtsman H, Avgerinos PC, et al. Abnormal hypothalamic-pituitary-adrenal function in anorexia nervosa. Pathophysiologic mechanisms in underweight and weight-corrected patients. N Engl J Med. 1986;314:1335-1342.
32. Walsh BT, Roose SP, Katz JL, et al. Hypothalamic-pituitary- adrenal-cortical activity in anorexia nervosa and bulimia. Psychoneuroendocrinology. 1987;12:131-140.
33. Kontula K, Andersson LC, Huttunen M, Pelkonen R. Reduced level of cellular glucocorticoid receptors in patients with anorexia nervosa. Horm Metab Res. 1982;14: 619-620.
34. Lanfranco F, Gianotti L, Picu A, et al. Effects of free fatty acids on ACTH and cortisol secretion in anorexia nervosa. Eur J Endocrinol. 2006;154:731-738.
35. Gold PW, Kaye W, Robertson GL, Ebert M. Abnormalities in plasma and cerebrospinal-fluid arginine vasopressin in patients with anorexia nervosa. N Engl J Med. 1983;308:1117-1123.
36. Connan F, Lightman SL, Landau S, Wheeler M, Treasure J, Campbell IC. An investigation of hypothalamic-pituitary-adrenal axis hyperactivity in anorexia nervosa: The role of CRH and AVP. J Psychiatr Res. 2007;41:131-143.
37. Misra M, Miller KK, Bjornson J, et al. Alterations in growth hormone secretory dynamics in adolescent girls with anorexia nervosa and effects on bone metabolism. J Clin Endocrinol Metab. 2003;88:5615-5623.
38. Douyon L, Schteingart DE. Effect of obesity and starvation on thyroid hormone, growth hormone, and cortisol secretion. Endocrinol Metab Clin North Am. 2002;31:173-189.
39. Katzman DK. Medical complications in adolescents with anorexia nervosa: A review of the literature. Int J Eat Disord. 2005;37:52-59.
40. Van Dam EW, Roelfsema F, Helmerhorst FH, et al. Low amplitude and disorderly spontaneous growth hormone release in obese women with or without polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87:4225-4230.
41. Bruni V, Filicetti MF, Pontello V. Open issues in anorexia nervosa: Prevention and therapy of bone loss. Ann N Y Acan Sci. 2006;1092:91-102.
42. Grinspoon S, Thomas E, Pitts S, et al. Prevalence and predictive factors for regional osteopenia in women with anorexia nervosa. Ann Intern Med. 2000;133:790-794.
43. Zipfel S, Seibel MJ, Löwe B, Beumont PJ, Kasperk C, Herzog W. Osteoporosis in eating disorders: A follow-up study of patients with anorexia and bulimia nervosa. J Clin Endocrinol Metab. 2001;86:5227-5233.
44. Herzog W, Minne H, Deter C, et al. Outcome of bone mineral density in anorexia nervosa patients 11.7 years after first admission. J Bone Miner Res. 1993;8:597-605.
45. Lucas AR, Melton LJ 3rd, Crowson CS, O'Fallon WM. Long-term fracture risk among women with anorexia nervosa: A population-based cohort study. Mayo Clin Proc. 1999;74:972-977.
46. Pafumi C, Ciotta L, Farina M, et al. Evaluation of bone mass in young amenorrheic women with anorexia nervosa. Minerva Ginecol. 2002;54:487-491.
47. Karlsson MK, Weigall SJ, Duan Y, Seeman E. Bone size and volumetric density in women with anorexia nervosa receiving estrogen replacement therapy and in women recovered from anorexia nervosa. J Clin Endocrinol Metab. 2000;85:3177-3182.
48. Viapiana O, Gatti D, Dalle Grave R, et al. Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight. Bone. 2007;40:1073-1077.
49. Grinspoon S, Thomas L, Miller, K, Herzog D, Klibanski A. Effects of recombinant human IGF-I and oral contraceptive administration on bone density in anorexia nervosa. J Clin Endocrinol Metab. 2002;87:2883-2891.
50. Stefanis N, Mackintosh C, Abraha HD, Treasure J, Moniz C. Dissociation of bone turnover in anorexia nervosa. Ann Clin Biochem. 1998;35:709-716.
51. Misra M, Kilbanski A. Anorexia nervosa and osteoporosis. Rev Endocr Metab Disord. 2006;7:91-99.
52. Hotta M, Fukuda I, Sato K, Hizuka N, Shibasaki T, Takano K. The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa. J Clin Endocrinol Metab. 2000;85:200-206.
53. Golden NH, Iglesias EA, Jacobson MS, et al. Alendronate for the treatment of osteopenia in anorexia nervosa: A randomized, double-blind, placebo-controlled trial. J Clin Endocrinol Metab. 2005;90:3179-3185.
54. Fosamax [package insert]. Whitehouse Station, NJ: Merck & Co Inc; 2000.
55. Iketani T, Kiriike N, Murray, et al. Effect of menatetrenone (vitamin K2) treatment on bone loss in patients with anorexia nervosa. Psychiatry Res. 2003;117:259-269.
56. Gordon CM, Grace E, Emans SJ, et al. Effects of oral dehydroepiandrosterone on bone density in young women with anorexia nervosa: A randomized trial. J Clin Endocrinol Metab. 2002;87:4935-4941.
57. Bianda T, Glatz Y, Bouillon R, Froesch ER, Schmid C. Effects of short-term insulin-like growth factor-I (IGF-I) or growth hormone (GH) treatment on bone metabolism and on production of 1,25-dihydroxycholecalciferol in GH-deficient adults. J Clin Endocrinol Metab. 1998;83:81-87.
58. Heer M, Mika C, Grzella I, Heussen N, Herpertz-Dahlmann B. Bone turnover during inpatient nutritional therapy and outpatient follow-up in patients with anorexia nervosa compared with that in healthy control subjects. Am J Clin Nutr. 2004;80:774-781.
59. Bachrach LK, Katzman DK, Litt IF, Guido D, Marcus R. Recovery from osteopenia in adolescent girls with anorexia nervosa. J Clin Endocrinol Metab. 1991;72:602-606.
60. Brown NW, Ward A, Surwit R, et al. Evidence for metabolic and endocrine abnormalities in subjects recovered from anorexia nervosa. Metabolism. 2003;52:296-302.
61. Ohwada R, Hotta M, Oikawa S, Takano K. Etiology of hypercholesterolemia in patients with anorexia nervosa. Int J Eat Disord. 2006;36:598-601.
62. Haagensen AL, Feldman HA, Ringelheim J, Gordon CM. Low prevalence of vitamin D deficiency among adolescents with anorexia nervosa. Osteoporosis Int. 2008;19:289-294.
63. Misra M, Tsai P, Anderson EJ, et al. Nutrient intake in community-dwelling adolescent girls with anorexia nervosa and in healthy adolescents. Am J Clin Nutr. 2006;84:698-706.
64. Apovian CM, McMahon MM, Bistrian BR. Guidelines for refeeding the marasmic patient. Crit Care Med. 1990;18:1030-1033.
65. Crook MA, Hally V, Panteli JV. The importance of the refeeding syndrome. Nutrition. 2001;17:632-637.
66. Smith T, Elia M. Artificial nutrition support in hospital: Indications and complications. Clin Med. 2006;6:457-460.
67. Mantzoros CS. The role of leptin in human obesity and disease: A review of current evidence. Ann Intern Med. 1999;130:671-680.
68. McMinn JE, Baskin DG, Schwartz MW. Neuroendocrine mechanisms regulating food intake and body weight. Obes Rev. 2000;1:37-46.
69. Cummings DE, Shannon MH. Roles for ghrelin in the regulation of appetite and body weight. Arch Surg. 2003;138: 389-396.
70. Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623-1630.
71. Grinspoon S, Gulick T, Askari H, et al. Serum leptin levels in women with anorexia nervosa. J Clin Endocrinol Metab. 1996;81:3861-3863.
72. Escobar L, Freire JM, Espinosa R, et al. Determination of insulin, leptin and neuropeptide y by radioimmunoanalysis in patients with morbid obesity and anorexia nervosa after therapeutic intervention [article in Spanish]. Rev Esp Med Nucl. 2002;21:3-11.
73. Baranowska B, Wasilewska-Dziubińska E, Radzikowska M, P?onowski A, Roguski K. Neuropeptide Y, galanin, and leptin release in obese women and in women with anorexia nervosa. Metabolism. 1997;46:1384-1389.
74. Chan JL, Mantzoros CS. Role of leptin in energy-deprivation states: Normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa. Lancet. 2005;366:74-85.
75. Lebrethon MC, Aganina A, Fournier M, Gérard A, Parent AS, Bourguignon JP. Effects of in vivo and in vitro administration of ghrelin, leptin and neuropeptide mediators on pulsatile gonadotrophin-releasing hormone secretion from male rat hypothalamus before and after puberty. J Neuroendocrinol. 2007;19:181-188.
76. Farooqi IS, Matarese G, Lord GM, et al. Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency. J Clin Invest. 2002;110:1093-1103.
77. Chan JL, Heist K, DePaoli AM, Veldhuis JD, Mantzoros CS. The role of falling leptin levels in the neuroendocrine and metabolic adaptation to short-term starvation in healthy men. J Clin Invest. 2003;111:1409-1421.
78. Modan-Moses D, Stein D, Pariente C, et al. Modulation of adiponectin and leptin during refeeding of female anorexia nervosa patients. J Clin Endocrinol Metab. 2007; 92:1843-1847.
79. Oświecimska J, Ziora K, Geisler G, Broll-Waśka K. Prospective evaluation of leptin and neuropeptide Y (NPY) serum levels in girls with anorexia nervosa. Neuro Endocrinol Lett. 2005;26:301-304.
80. Misra M, Miller KK, Almazan C, et al. Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity. J Clin Endocrinol Metab. 2004;89:3486-3495.
81. Holtkamp K, Mika C, Grzella I, et al. Reproductive function during weight gain in anorexia nervosa. Leptin represents a metabolic gate to gonadotropin secretion. J Neural Transm. 2003;110:427-435.
82. Otto B, Cuntz U, Fruehauf E, et al. Weight gain decreases elevated plasma ghrelin concentrations of patients with anorexia nervosa. Eur J Endocrinol. 2001;145:669-673.
83. Nakahara T, Kojima S, Tanaka M, et al. Incomplete restoration of the secretion of ghrelin and PYY compared to insulin after food ingestion following weight gain in anorexia nervosa. J Psychiatr Res. 2007;41:814-820.
84. Dostálová I, Haluzík M. The role of ghrelin in the regulation of food intake in patients with obesity and anorexia nervosa. Physiol Res. 2008 Apr 1 [Epub ahead of print].
85. Misra M, Miller KK, Kuo K, et al. Secretory dynamics of ghrelin in adolescent girls with anorexia nervosa and healthy adolescents. Am J Physiol Endocrinol Metab. 2005;289:E347-E356.
86. Miljic D, Pekic S, Djurovic M, et al. Ghrelin has partial or no effect on appetite, growth hormone, prolactin, and cortisol release in patients with anorexia nervosa. J Clin Endocrinol Metab. 2006;91:1491-1495.
87. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol (Oxf). 2004;60:592-599.
88. Nedvídková J, Krykorková I, Barták V, et al. Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J Clin Endocrinol Metab. 2003;88:1678-1682.
89. Otto B, Tschöp M, Frühauf E, et al. Postprandial ghrelin release in anorectic patients before and after weight gain. Psychoneuroendocrinology. 2005;30:577-581.